News
Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...
6d
Zacks Investment Research on MSNPfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should KnowPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman ...
Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...
Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...
Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...
Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than ...
While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their ...
Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...
Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results